Showing results (61-70 of 463) with videos related to
Sort By:
Pageof 47
Current Oncology Reports|December 14, 2006
Net clinical benefit: functional endpoints in brain tumor clinical trialsTerri S Armstrong, Mark R GilbertOncology (Williston Park, N.Y.)|June 21, 2013
Treatment recommendations for anaplastic oligodendrogliomas that are codeletedMark D Anderson, Mark R GilbertCurrent Neurology and Neuroscience Reports|June 11, 2008
Use of complementary and alternative medical therapy by patients with primary brain tumorsTerri S Armstrong, Mark R GilbertActa Neuropathologica Communications|August 18, 2025
High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three casesEric A Goethe, Rasha Alfattal, Subhiksha Srinivasan, et al.Journal of Neuro-Oncology|June 25, 2025
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastomaPushan Dasgupta, Heather Lin, Gayatri Kumar, et al.Oncotarget|September 1, 2016
GBM-associated mutations and altered protein expression are more common in young patientsSherise D Ferguson, Joanne Xiu, Shiao-Pei Weathers, et al.Neuro-Oncology|March 19, 2016
Creating clinical trial designs that incorporate clinical outcome assessmentsMark R Gilbert, Lawrence Rubinstein, Glenn LesserCancer Control : Journal of the Moffitt Cancer Center|April 25, 2003
Advances in molecular therapies in patients with brain tumorsIvo W Tremont-Lukats, Mark R GilbertNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 21, 2016
Toward Personalized Targeted Therapeutics: An OverviewShiao-Pei S Weathers, Mark R GilbertOncology Nursing Forum|March 11, 2005
Chemotherapy-induced peripheral neuropathyTerri Armstrong, Lois Almadrones, Mark R GilbertPageof 47